TELA Bio, Inc. provided revenue guidance for the year 2024. For the year, the company expects Increased full year 2024 revenue guidance to $74.5 million to $76.5 million, representing 27% to 31% year-over-year growth.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.5 USD | -0.54% | -5.98% | -16.92% |
May. 20 | TELA Bio, Inc. Appoints Greg Firestone as Chief Commercial Officer | CI |
May. 10 | Piper Sandler Adjusts Price Target on TELA Bio to $10 From $12, Maintains Overweight Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.92% | 136M | |
-6.54% | 179B | |
-0.32% | 108B | |
-2.05% | 69.03B | |
-7.14% | 45.83B | |
+12.24% | 45.39B | |
+8.60% | 43.17B | |
+15.37% | 29.89B | |
+13.65% | 25.49B | |
-6.64% | 23.95B |
- Stock Market
- Equities
- TELA Stock
- News TELA Bio, Inc.
- TELA Bio, Inc. Provides Revenue Guidance for the Year 2024